Role of central mu-opioid receptors in the modulation of nitric oxide production by splenocytes

Journal of Neuroimmunology

Volumn 89, Issue 1-2, 1998, Pages 150-159

  Schneider, Gabrielle M ^a   Lysle, Donald T ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

DAMGO; DPDPE; Neuroimmunomodulation; Nitric oxide; Opioids; Rat; Toxic shock syndrome toxin; U69,593

Indexed keywords

17 METHYLNALTREXONE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; IMMUNOMODULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; TOXIC SHOCK SYNDROME;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; BACTERIAL TOXINS; BENZENEACETAMIDES; CELL DIVISION; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; ENTEROTOXINS; ENZYME INHIBITORS; INJECTIONS, INTRAVENTRICULAR; LYMPHOCYTES; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NEUROIMMUNOMODULATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PYRROLIDINES; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, INBRED LEW; RECEPTORS, OPIOID, MU; SPLEEN; SUPERANTIGENS;

EID: 0032516789     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00128-3     Document Type: Article

References (62)

1. Abrass C.K., O'Connor S.W., Scarpace P.J., Abrass I.B. Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. Journal of Immunology. 135:1985;1338-1341.
2. Albina J.E., Henry W.L. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. Journal of Surgical Research. 50:1991;403-409.
3. Al-Ramadi B.K., Meissler J.J., Huang D., Eisenstein T.K. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. European Journal of Immunology. 22:1992;2249-2254.
4. Appel N.M., Kiritsy-Roy J.A., Van Loon G.R. Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increases in central sympathetic outflow. Brain Res. 378:1986;8-20.
5. Bayer B.M., Daussin S., Hernandez M., Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid-dependent mechanism. Neuropharmacology. 29:1990;369-374.
6. Bayer B.M., Gastonguay M.R., Hernandez M.C. Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology. 23:1992;117-124.
7. Buckingham J.C. Secretion of corticotropin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology. 35:1982;111-116.
8. Casella A.M., Guardiola H., Renaud F.L. Inhibition by opioids of phagocytosis in peritoneal macrophages. Neuropeptides. 18:1991;35-40.
9. Costa Rosa L.F.B.P., Safi D.A., Cury Y., Curi R. Effect of epinephrine on glucose metabolism and hydrogen peroxide content in incubated rat macrophages. Biochemical Pharmacology. 44:1992;2235-2241.
10. Eisenstein T.K., Huang D., Meissler J.J., Al-Ramadi B. Macrophage nitric oxide mediates immunosuppression in infectious inflammation. Immunobiology. 191:1994;493-502.
11. Emmerson P.J., Liu M.R., Woods J.H., Medzihradsky F. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. Journal of Pharmacology and Experimental Therapeutics. 271:1994;1630-1637.
12. Fecho K., Dykstra L.A., Lysle D.T. Evidence for β-adrenergic receptor involvement in the immunomodulatory effects of morphine. Journal of Pharmacology and Experimental Therapeutics. 265:1993;1079-1087.
13. Fecho K., Maslonek K.A., Coussons-Read M.E., Dykstra L.A., Lysle D.T. Macrophage-derived nitric oxide is involved in the depressed Con A-responsiveness of splenic lymphocytes from rats administered morphine in-vivo. Journal of Immunology. 152:1994;5845-5852.
14. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation. Journal of Pharmacology and Experimental Therapeutics. 272:1995;477-483.
15. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. Journal of Pharmacology and Experimental Therapeutics. 276:1996;626-636.
16. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. Journal of Pharmacology and Experimental Therapeutics. 277:1996;633-645.
17. Felten D.L., Felten S.Y., Carlson S.L., Olschowka J.A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. Journal of Immunology. 135:1985;755s-765s.
18. Fu Y., Blankenhorn E.P. Nitric oxide-induced anti-mitogenic effects in high and low responder strains. Journal of Immunology. 148:1992;2217-2222.
19. Galligan J.J., Mosberg H.I., Hurst R., Hruby V.J., Burks T.F. Central delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioid. Journal of Pharmacology and Experimental Therapeutics. 229:1984;641-648.
20. George R., Way E.L. The role of the hypothalamus in pituitary-adrenal activation and antidiuresis by morphine. Journal of Pharmacology and Experimental Therapeutics. 125:1959;111-115.
21. Goldstein A. Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors. Trends Pharmacol. Sci. 8:1987;456-466.
22. 15N ]nitrate in biological fluids Anal. Biochem. 126:1982;131-136.
23. Green S.J., Meltzer M.S., Hibbs J.B., Nacy C.A. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. Journal of Immunology. 144:1990;278-283.
24. Hadden J.W., Hadden E.M., Middleton E. Jr. Lymphocyte blast transformation: I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell. Immunol. 1:1970;583-595.
25. Hoffman R.A., Langrehr J.M., Billiar T.R., Curran R.D., Simmons R.L. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. Journal of Immunology. 145:1990;2220-2226.
26. Hu X., Goldmuntz E.A., Brosnan C.F. The effect of norepinephrine on endotoxin-mediated macrophage activation. Journal of Neuroimmunology. 32:1991;35-42.
27. James S.L., Glaven J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. Journal of Immunology. 143:1989;4208-4212.
28. Jessop J.J., Taplits M.S. Effects of high doses of morphine on Con-A induced lymphokine production in vitro. Immunopharmacology. 22:1991;175-184.
29. Joseph D.B., Bidlack J.M. The kappa-opioid receptor expressed on the mouse lymphoma cell line R1.1 contains a sulfhydryl group at the binding site. European Journal of Pharmacology. 267:1994;1-6.
30. Lawrence D.M., Joseph D.B., Bidlack J.M. Kappa opioid receptors expressed on three related thymoma cell lines: differences in receptor-effector coupling. Biochem. Pharmacol. 49:1995;81-89.
31. Lockwood L.L., Silber L.H., Fleshner M., Laudenslager M.L., Watkins L.R., Maier S.F. Morphine-induced decreases in in vivo antibody responses. Brain, Behavior, Immunity. 8:1994;24-36.
32. Lotti V., Kokka N., George R. Pituitary-adrenal activation following intrahypothalamic microinjection of morphine. Neuroendocrinology. 4:1969;326-332.
33. Loveland B.E., Jarrott B., McKenzie I.F.C. The detection of β-adrenoceptors on murine lymphocytes. Int. J. Immunopharmacol. 3:1981;45-55.
34. Lysle D.T., Coussons M.E., Watts V.J., Bennett E.H., Dykstra L.A. Morphine-induced alterations of immune status: dose-dependency and compartment specificity and antagonism by naltrexone. Journal Pharmacology and Experimental Therapeutics. 265:1993;1071-1078.
35. Lysle D.T., Hoffman K.E., Dykstra L. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. Journal of Pharmacology and Experimental Therapeutics. 277:1996;1533-1540.
36. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N., Chen H., Mudgett J.S. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650.
37. Madden J.J., Donahoe R.M., Zwemer-Collins, Shafer D.A., Falek A. Binding of naloxone to human T lymphocytes. Biochem. Pharmacol. 36:1987;4103-4109.
38. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 248:1990;705-711.
39. 3H -clonidine binding in membranes prepared from guinea-pig spleen Clin. Exp. Pharmacol. Physiol. 9:1982;77-87.
40. Mehrishi J.N., Mills I.H. Opiate receptors on lymphocytes and platelets in man. Clin. Immunol. Immunopathol. 27:1983;240-249.
41. Meyer M.E., Meyer M.E. Behavioral effects of the mu-opioid peptide agonists DAMGO, DALDA, and PL017 on locomotor activities. Pharmacol. Biochem. Behav. 46:1993;391-395.
42. Miles B.A., Lafuse W.P., Zwilling B.S. Binding of α-adrenergic receptors simulates the anti-mycobacterial activity of murine peritoneal macrophages. Journal of Neuroimmunology. 71:1996;19-24.
43. Mills C. Molecular basis of 'suppressor' macrophages: arginine metabolism via the nitric oxide synthetase pathway. Journal of Immunology. 146:1991;2719-2723.
44. Mills C.D., Shearer J., Evans R., Caldwell M.D. Macrophage arginine metabolism and the inhibition or stimulation of cancer. Journal of Immunology. 149:1992;2709-2714.
45. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB Journal. 6:1992;3051-3064.
46. Ovadia H., Nitsan P., Abramsky O. Characterization of opiate binding sites on membranes of rat lymphocytes. Journal of Neuroimmunology. 21:1989;93-102.
47. Pascual D.W., Pascual V.H., Bost K.L., McGhee J.R., Oparil S. Nitric oxide mediates immune dysfunction in the spontaneously hypertensive rat. Hypertension. 21:1992;185-194.
48. Paxinos, G., Watson, C., 1986. The rat brain in stereotaxic coordinates, 2nd edn., Academic Press, San Diego.
49. Peterson P.K., Sharp B., Gekker G., Keane W.F. Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. Journal of Immunology. 138:1987;3907-3912.
50. Radojcic T., Baird S., Darko D., Smith D., Bulloch K. Changes in β-adrenergic receptor distribution on immunocytes during differentiation: an analysis of T cell and macrophages. J. Neurosci. Res. 30:1991;328-335.
51. Rojavin M., Szabo I., Bussiere J.L., Rogers T.J., Adler M.W., Eisenstein T.K. Morphine treatment in-vitro or in-vivo decreases phagocytic functions of murine macrophages. Life Sciences. 53:1993;997-1006.
52. Shavit Y., DePaulis A., Martin F.C., Terman G.W., Pechnick R.N., Zane C.J., Gale R.P., Liebeskind J.C. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. U.S.A. 83:1986;7114-7117.
53. Spanagel R., Almeida O.F.X., Shippenberg T.S. Evidence that norbinaltorphimine can function as antagonist at multiple opioid receptor subtypes. European Journal of Pharmacology. 264:1994;157-162.
54. Stuehr D.J., Nathan C.F. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. Journal of Experimental Medicine. 169:1989;1543.
55. Suemaru S., Hashimoto K., Ota Z. Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary-adrenocortical activity. Endocrinol. Jpn. 33:1986;441-448.
56. Vincendeau P., Daulouede S., Veyret B., Darde M.L., Bouteille B., Lemesre J.L. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Experimental Parasitology. 75:1992;353-360.
57. Weber R.J., Pert A. The periaqueductal grey matter mediates opiate-induced immunosuppression. Science. 245:1989;188-190.
58. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Mocado S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
59. G-monomethyl-L-arginine. J. Exp. Med. 179:1994;651-660.
60. White H., Herman A., Pullen A.M., Kubo R., Kappler J.W., Marrack P. The Vβ specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 56:1989;27-35.
61. 3H ]alprenolol binding J. Clin. Invest. 57:1976;149-155.
62. Wybran J., Appelboom T., Famey J.P., Govaerts A. Suggestive evidence for receptors for morphine and methionine enkephalin on normal human blood T-lymphocytes. Journal of Immunology. 123:1979;1068-1070.